Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

EnteroBiotix begins phase 2 trial of IBS treatment

April 3, 2024 Research and Development EnteroBiotix, Gastrointestinal tract, IBS, irritable bowel syndrome

EnteroBiotix has announced that it has dosed the first patient in its multi-centre, randomised, double-blind, placebo controlled clinical trial, which …
News

FDA accepts BLA for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan for breast cancer treatment

April 2, 2024 Research and Development AstraZeneca, Daiichi Sankyo, FDA, Oncology, bla, breast cancer

AstraZeneca and Daiichi Sankyo have announced that their Biologics License Application (BLA) for datopotamab deruxtecan (Dato-Dxd) has been accepted in …
News

Heidelberg Pharma gains FDA ODD for ATAC candidate

March 27, 2024 Research and Development FDA, Oncology, heidelberg pharma, multiple myeloma

Heidelberg Pharma has announced that it has gained Orphan Drug Designation (ODD) from the US Food and Drug Administration (FDA) …
News

Curve Therapeutics’ CSO publishes research on HIF inhibition for cancer treatment

March 26, 2024 Research and Development Cancer, Curve Therapeutics, HIF inhibition, Oncology, oncology

Curve Therapeutics has announced that its chief scientific officer, Professor Ali Tavassoli has published research in the Journal of the …
News

Sosei Heptares doses first patient in trial for inflammatory bowel disease treatment

March 21, 2024 Research and Development Gastrointestinal tract, Sosei Heptares, clinical trial, inflammatory bowel disease, phase 1 trial

Sosei Heptares has announced that it has dosed the first patient in its phase 1 trial assessing a novel EP4 …
News

J&J MedTech to work with NVIDIA for surgical AI

March 19, 2024 Research and Development Johnson & Johnson MedTech, NVIDIA, Pharmacy, surgery, surgical AI

Johnson & Johnson (J&J) MedTech has announced that it is working in collaboration with NVIDIA to accelerate and scale artificial …
News

GSK shares data from phase 3 trial for Jemperli combinations for endometrial cancer treatment

March 18, 2024 Research and Development GSK, Jemperli, Oncology, clinical trial, endometrial cancer, women's health

GSK has announced positive results from part 1 and part 2 of its RUBY/ENGOT-EN6/GOG3031/NSGO phase 3 trial for Jemperli (dostarlimab) …
News

Merck shares results for Keytruda in cervical cancer treatment

March 18, 2024 Research and Development Merck, Oncology, cervical cancer, keytruda, women's health

Merck, known as MSD outside of the US and Canada, has announced positive results from the phase 3 KEYNOTE-A18 trial, …
News

Allumiqs and Prolytix enter partnership for acceleration of drug discovery and development

March 15, 2024 Research and Development Allumiqs, Pharmacy, drug discovery, partnership

Allumiqs and Prolytix have announced that they have entered into a long-term, strategic partnership with the aim of providing collaboratinve …
News

Bayer and Aignostics to collaborate for AI oncology research

March 14, 2024 Research and Development AI, Bayer, Oncology, research

Bayer and Aignostics have announced that they have entered into a strategic collaboration for several artificial intelligence (AI)-powered approaches for …
News

EC approves Pfizer’s Prevenar 20 to protect paediatric patients against pneumococcal disease

March 13, 2024 Research and Development EC, EMA, Infections and infestations, Prevnar 20, pneumococcal disease

Pfizer has announced that the European Commission (EC) has granted marketing authorisation for Prevenar 20, the company’s 20-valent pneumococcal conjugate …
News

Merck plans to conduct trials for HPV vaccines

March 13, 2024 Research and Development Immunology, Merck, vaccines

Merck, known as MSD outside of the US and Canada, has announced that it is planning to initiate clinical development …
News

Sanofi shares phase 2b results for dermatitis treatment

March 12, 2024 Research and Development Dermatology, Sanofi, amlitelimab, atopic dermatitis, clinical trial, dermatitis

Sanofi has shared positive results from part 2 of the investigational phase 2b STREAM-AD study of amlitelimab for adult patients …
News

Roche shares data on novel solution for continuous glucose monitoring

March 8, 2024 Research and Development Diabetes, Medical device, Roche, continuous glucose monitoring, diabetes

Roche has shared the latest data on its novel solution for continuous glucose monitoring (CGM), including a CGM sensor and …
News

GSK shares results from phase 3 trial for Blenrep for treatment of multiple myeloma

March 7, 2024 Research and Development Blenrep, GSK, Oncology, clinical trial, multiple myeloma

GSK has announced positive results from an interim analysis of the DREAMM-8 phase 3 head-to-head trial which assesses Blenrep (belantamab …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026